Six-month-old 3×Tg mice exhibit early AD symptoms but no tau pathology, but Aβ deposition and synaptic dysfunction are already present, which manifests as early cognitive deficits, and these mice can be used as an AD-MCI model. This evidence concerns the gene MAPT and Alzheimer disease.